Corporate DisclosureORIONPHARM
ORIONPHARM Corporate Disclosure — 28 January 2020
Announcement summary
- What happened
- ORIONPHARM published a corporate disclosure on 28 January 2020. Read the full announcement for details.
- Company
- Orion Pharma Ltd.
- Announcement published
Original announcement
(Continuation news of ORIONPHARM): Consolidated NAV per share including revaluation surplus was Tk. 75.73 as on December 31, 2019 and Tk. 75.19 as on June 30, 2019. Consolidated NAV per share excluding revaluation surplus was Tk. 67.58 as on December 31, 2019 and Tk. 66.98 as on June 30, 2019. (end)
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616aceb25a6b000040057956
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from ORIONPHARM
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.